lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Expression and regulation

Regulation From TransFac database

Egr-1(h) --> IL3(h) (DNA binding).
Egr-1(h) --> FOSL1(h) (DNA binding; transactivation).
Egr-1(h) --> TNF(h) (DNA binding; transactivation).
Egr-1(h) --> FASLG(h) (DNA binding; transactivation).
Egr-1(h) --> MAOB(h) (DNA binding; transactivation).
Egr-1(h) --> RET(h) (DNA binding; transregulation).
Egr-1(h) --> COL1A2(h) (DNA binding).
Egr-1(h) + AR-isoform1(h) <==> Egr-1(h):AR-isoform1(h) (binding)
Egr-1(h) + AR(h) <==> Egr-1(h):AR(h) (binding)
Egr-1(h) --> KLK3(h) (transactivation)
Egr-1(h) + NF-AT2(m.s.) <==> Egr-1(h):NF-AT2(m.s.) (binding)
Egr-1(h) + NF-AT1(m.s.) <==> Egr-1(h):NF-AT1(m.s.) (binding)
Egr-1(h) --> COL2A1(h) (DNA binding).
Egr-1(h) --> F3(h) (DNA binding; transactivation).
Egr-1(h) --/ ABCA2(h) (DNA binding; transrepression).
Egr-1(h) --> PTGES(h) (DNA binding).
Egr-1(h) --> ACE(h) (DNA binding).
Egr-1(h) --> SOD1(h) (DNA binding; transactivation).
Egr-1(h) --> NDRG1(h) (DNA binding).
Egr-1(h) --> CCR5(h) (DNA binding).
Egr-1(h) --> GADD45A(h) (DNA binding).
Egr-1(h) + Sp1(h) <==> Egr-1(h):Sp1(h) (binding)
Egr-1(h) --> Egr1(m) (DNA binding).
Egr-1(h) --> IL2RB(h) (DNA binding).
Egr-1(h) --> NFKB1(h) (DNA binding; transactivation).
Egr-1(h) --> CCND1(h) (DNA binding).
Egr-1(h) --> FGF2(h) (DNA binding).
Egr-1(h) --> PPARG(h) (DNA binding; transactivation).
Egr-1(h) --> FLT1(h) (DNA binding).
Egr-1(h) --> ID1(h) (DNA binding).
Egr-1(h) --> CAT(h) (DNA binding).
Egr-1(h) --> PTP4A1(h) (DNA binding).
Egr-1(h) --> NAB2(h) (DNA binding).
Egr-1(h) --> SLC9A3(h) (DNA binding).
Egr-1(h) --> SLC9A2(h) (DNA binding).
Egr-1(h) --> LDLR(h) (DNA binding).
Egr-1(h) --> IL2RB(m) (DNA binding).
Egr-1(h) --> Chga(m) (DNA binding; transactivation).
Egr-1(h) --> HPSE(h) (transactivation)
Egr-1(h) --> PDGFA(h) (DNA binding).
Egr-1(h) --> BIRC5(h) (DNA binding).
Egr-1(h) --> CD44(h) (DNA binding).
Egr-1(h) --> ATF3(h) (DNA binding).
Egr-1(h) --> ID2(h) (DNA binding).
Egr-1(h) --> c-myb(h) (DNA binding).
Egr-1(h) --> ACTA2(h) (DNA binding).
Egr-1(h) --> FN1(h) (DNA binding).
Egr-1(h) --> TBXA2R(h) (DNA binding).
Egr-1(h) --> GNAQ(h) (DNA binding).
Egr-1(h) --> PTPRZ1(h) (DNA binding; transactivation).
Egr-1(h) --> GDF15(h) (DNA binding).
Egr-1(h) --> FYN(h) (transactivation)
Egr-1(h) --> IGF2(h) (DNA binding).
Egr-1(h) --> HIF1A(h) (DNA binding).
Egr-1(h) --> PRDM1(h) (DNA binding).
Egr-1(h) --> SRD5A1(h) (DNA binding).
EGR1(h) --> Egr-1(h) (expression).
(PDGFB(h))2 --> Egr-1(h) (increase of abundance)
Egr-1(h) --> IL2(h) (DNA binding; transactivation).
Egr-1(h) --> ELK1(h) (DNA binding; transactivation).
Egr-1(h) --> EGFR(h) (DNA binding; transregulation).
Egr-1(h) --/ TGFBR2(h) (DNA binding; transrepression).
Egr-1(h) --/ c-Met(m) (decrease of abundance)
Egr-1(h) --/ c-Met(h) (decrease of abundance)
Egr-1(h) --/ MET(h) (transrepression)
Egr-1(h) + RelA-p65(h) <==> Egr-1(h):RelA-p65(h) (binding)
Egr-1(h) --> TNF(h) (transactivation)
NF-AT2(m.s.) + Egr-1(h) <==> NF-AT2(m.s.):Egr-1(h) (binding)
NF-AT1(m.s.) + Egr-1(h) <==> NF-AT1(m.s.):Egr-1(h) (binding)
Egr-1(h) --/ ADRB1(r) (DNA binding; transrepression).
Egr-1(h) --> SREBF1(h) (DNA binding).
Egr-1(h) --> PDGFC(h) (DNA binding).
Egr-1(h) --> Chga(m) (transactivation)
Egr-1(h) --> ATF3(h) (transactivation)
EGR1(h) --> Egr-1(h) (expression).

Human Primary Tumor Samples (U95)  | Top

Click to view sample information

Human U133A/GNF1H Gene Atlas  | Top